NASDAQ: BCRX · Drug Manufacturers - Specialty & Generic
Over the past week, Biocryst Pharmaceuticals (BCRX) logged about 30 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 32% bullish but is sharply divided: Reddit runs 67% bullish while News sits at just 11%. Wall Street is more constructive, with 10 of 11 analysts rating BCRX a buy.
There is little buzz around BCRX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 91% buy share sits next to a crowd that ranges from News at 11% to Reddit at 67%. No other tracker puts the two side by side.
11 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $20.82.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 59 points above the crowd average of 32%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 67% bullish while News sits at 11%, a 56-point spread that single-source trackers miss.
Over the 30-day window, Biocryst Pharmaceuticals (BCRX) buzz held subdued around 18.3 while the price drifted up 4.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.4M shares. Updated Aug 15, 2026. Over the last 7 trading days, BCRX gained 4.7%. Buzz activity in the recent week averaged 24.9 and was relatively stable, swinging between 18.3 and 30.4. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 8 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BCRX and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BCRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (10 / 1 / 0) |
| Crowd bullish (7d) | 32% |
| Avg price target | $20.82 |
| Most bullish source | Reddit, 67% |
| Most bearish source | News, 11% |
| Sentiment spread | 56 pts |
| Mentions (7d) | 30 |
| Market cap | $2.51B |
| P/E · Forward P/E | n/a · 28.9 |
| EPS · Beta | -$1.30 · 0.6 |
| Revenue (TTM) | $940.6M · -41% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from Reddit, X and News sources, Biocryst Pharmaceuticals (BCRX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 32% bullish across 3 active sources. Those sources contribute 30 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Biocryst Pharmaceuticals (BCRX) is fairly quiet with 9 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 67% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Biocryst Pharmaceuticals (BCRX), averaging 32% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 67% bullish and News at 11%, a 56-point spread. On the professional side, 10 of 11 analysts rate BCRX a buy.
Of the 11 analysts covering Biocryst Pharmaceuticals (BCRX), 10 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $20.82. That puts the street ahead of the crowd, which averages 32% bullish.
Biocryst Pharmaceuticals (BCRX)'s cross-source average is bearish at 32% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 67% bullish, X reads 17% bullish and news coverage is the most negative at 11% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Biocryst Pharmaceuticals (BCRX) at 32% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is news at 11% bullish. 3-day activity momentum is falling across X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 12 mentions (40% of total volume). Reddit contributes 9 mentions and News contributes 9 mentions. The cross-source average is bearish at 32% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BCRX's sell signal at 93/100 conviction reflects a bearish cross-source average at 32% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The BCRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key